SecBot SecBot
144 ·Filed Nov 6, 2026

GILD

GILEAD SCIENCES, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed10d 5h ago SEC0001950047-26-010782
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine insider sale of shares acquired from RSU vesting. The amount is immaterial relative to the company's market cap. No further action warranted; monitor for any unusual pattern of larger insider sales in future filings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$169.32
T+0 close · Nov 6, 2026 · via day close
Latest settled
−1.03%
T+5 · $167.58
Vs SPY
+0.67%
α at T+5
Next horizon
T+20
in 21d
  1. T+0 · Nov 9 $169.32entry
  2. T+1 · 7d ago +0.92%α +1.28% · $170.87
  3. T+5 · 15h ago −1.03%α +0.67% · $167.58
  4. T+20 · in 21d Pending
  5. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Keeley Cain Wettan, an officer of Gilead Sciences, filed a Form 144 to sell 3,399 shares of common stock with an approximate market value of $569,570. The shares were acquired through vesting of restricted stock units between August and September 2026. The sale is a routine disposition of equity compensation by an insider, representing a negligible fraction of the company's $216.4B market cap.

Key Facts

  • Insider: Keeley Cain Wettan, officer of Gilead Sciences
  • Shares to be sold: 3,399 shares of common stock
  • Estimated value: $569,570.43
  • Shares acquired via vesting of restricted stock units from 08/10/2026 through 09/10/2026
  • Filing date: 2026-11-06
  • Broker: Morgan Stanley Smith Barney LLC Executive Financial Services

Financial Impact

Sale of 3,399 shares worth ~$570K, representing ~0.00026% of Gilead's $216.4B market cap

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur
  • No additional context on the insider's total holdings is provided to assess proportionality

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010782
Document: 0001950047-26-010782-index.html0001950047-26-010782
Document: 0001950047-26-010782.txt0001950047-26-010782

Track record

30 reports on GILD

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
  2. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
  3. Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
  6. Nov 6, 202610d ago 144 Neutral 2/10 Viewing Entry $169.32 Now $167.58 −1.03% settles Feb 5
  7. Nov 4, 202612d ago 144 Neutral 3/10 Entry $167.57 Now $167.58 +0.01% settles Feb 3
  8. Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
  9. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
  10. Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (11h 43m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 6, 2026